Related by context. All words. (Click for frequent words.) 68 Azedra 65 MYDICAR ® 65 Allovectin 7 R 64 Stedivaze 64 LEUKINE 64 Corgentin 64 Phase IIB 64 Anturol TM 64 Triolex 64 EP #R 63 Bezielle 63 Icatibant 63 Chrysalin 63 Fibrillex TM 63 TOLAMBA 63 phase IIa clinical 62 tanespimycin 62 YONDELIS 62 AZILECT ® 62 Traficet EN 62 Clolar ® 62 Aurexis 62 UPLYSO 62 tezampanel 62 OvaRex ® MAb 62 Factor VIIa 62 EFAPROXYN 62 ELACYT 62 CoFactor 62 CCX# 61 BioSTAR R 61 Phenoptin 61 Alvesco R 61 FOLOTYN ® 61 INCB# [001] 61 NGX# 61 Trofex 61 MAGE A3 ASCI 61 Phase IIIb clinical 61 liprotamase 61 mertansine 61 OMS#HP 61 elotuzumab 61 TORISEL 61 HuMax CD4 61 MYDICAR 61 catheter occlusion 61 ularitide 61 Androxal TM 61 Phase Ib study 61 Xanafide 61 methylnaltrexone 61 PRT# 61 SNT MC# 61 PREOS 61 oral prodrug 61 CA9 SCAN 61 Ophena TM 61 HuMax EGFr 61 Dyloject TM 61 PLK1 SNALP 61 ProSavin 60 eniluracil 60 HDL Selective Delipidation 60 OMNARIS HFA 60 ENTEREG ® 60 mifamurtide 60 Certican 60 NV1FGF 60 tafamidis 60 talactoferrin 60 Archexin 60 KNS # 60 Octreolin 60 Proxinium TM 60 GAMMAGARD 60 APOPTONE 60 Firazyr 60 OncoVEX GM CSF 60 ARIKACE ™ 60 PLX cells 60 CR# vcMMAE 60 Androxal 60 NP2 Enkephalin 60 MultiStem 60 phase IIb clinical 60 CBLC# 60 oral ridaforolimus 60 AeroLEF TM 60 ganetespib 60 IRX 2 60 ALTROPANE 60 KRN# 60 torezolid phosphate 60 CINQUIL 60 vorinostat 60 teriflunomide 60 sumatriptan DosePro 60 Cinryze TM 60 tezampanel NGX# 59 GRN# 59 TOCOSOL Paclitaxel 59 Plicera 59 Cleviprex TM clevidipine 59 Vasovist 59 PXD# 59 STRIDE PD 59 rFIXFc 59 Dasatinib 59 rasagiline tablets 59 Catena ® 59 Ereska 59 pseudobulbar affect PBA 59 HuLuc# 59 TYZEKA 59 alvimopan 59 ADAGIO study 59 Aviptadil 59 ruxolitinib 59 Elagolix 59 cangrelor 59 Pirfenidone 59 Anturol 59 TREDAPTIVE 59 PROMACTA 59 INCB# [003] 59 NexACT 59 obatoclax 59 INT# [002] 59 cannabinor 59 PREOS R 59 eltrombopag 59 ITAX 59 PEGylated anti 59 Symadex 59 EndoTAG TM -1 59 Amplimexon 59 Panzem 59 ALGRX 59 phase IIa 59 Amrubicin 59 HuMax CD# 59 Plenaxis TM 59 Dalbavancin 59 MERLIN TIMI 59 Teriparatide 59 SEBIVO 59 MGd 59 pralatrexate 59 alvespimycin 59 TELCYTA 58 riociguat 58 Tezampanel 58 PDE4 inhibitor 58 CIMZIA ™ 58 Viramidine 58 Virulizin ® 58 tramiprosate 58 teduglutide 58 #D#C# 58 Fibrin Pad 58 BRIM2 58 Golimumab 58 ARCOXIA 58 C1 INH 58 Ventavis 58 Tyrima 58 Pivotal Phase III 58 Inhalation Solution 58 HQK 58 Emselex 58 LY# [003] 58 BAY #-# 58 Cx# [002] 58 novel VDA molecule 58 Evoltra 58 atacicept 58 Cethrin 58 refractory angina 58 ataluren 58 LEVADEX ™ 58 JAK inhibitor 58 Raptiva ® 58 Relivar 58 Zolinza 58 rilonacept 58 MoxDuo IR 58 preclinically 58 Mepact 58 posaconazole 58 Tamibarotene 58 Phase 2a clinical 58 NEUMUNE 58 OMNARIS Nasal Spray 58 reslizumab 58 pharmacokinetic PK study 58 vosaroxin 58 ABRAXANE TM 58 MyoCell 58 LymphoStat B 58 CYPHER R Sirolimus eluting 58 cancer immunotherapies 58 rFVIIa 58 selective androgen receptor modulator 58 pomalidomide 58 systemically administered 58 MAA submission 58 Entereg R 58 Soliris eculizumab 58 Torisel 57 Viprinex TM 57 CTAP# Capsules 57 Neurodex 57 vidofludimus 57 recurrent glioma 57 AZILECT R 57 sipuleucel T 57 Pimavanserin 57 topical NSAID 57 Onbrez Breezhaler 57 Curaxin 57 Increlex ® 57 Nasulin 57 ZOLINZA 57 SEPET TM 57 metaglidasen 57 Bronchitol 57 Aflibercept 57 cobiprostone 57 IL# PE#QQR 57 Xinlay 57 Exelixis compounds 57 novel oral anticoagulant 57 KALBITOR 57 HGS ETR2 57 darapladib 57 CYT# potent vascular disrupting 57 XmAb# 57 investigational monoclonal antibody 57 REMINYL ® 57 LEVADEX 57 Desmoteplase 57 EDEMA3 57 ELND# 57 Campath ® 57 rhThrombin 57 Rasagiline 57 ORENCIA R 57 OncoVEX 57 Vandetanib 57 PEG Interferon lambda 57 AzaSite Plus 57 CCX# B 57 elagolix 57 CAPHOSOL 57 Zenvia ™ 57 Combidex 57 Oxiplex 57 CANCIDAS 57 DCVax R 57 fibrotic disease 57 LT NS# 57 clinical trials Multikine 57 investigational humanized monoclonal antibody 57 Omigard 57 VAPRISOL 57 fosbretabulin 57 pradefovir 57 florbetaben 57 GATTEX 57 Fx #A 57 Azilect ® 57 vivo validation 57 Valdoxan 57 EchoCRT 57 ADVEXIN 57 Azixa 57 efficacy tolerability 57 Clonicel 57 GLYX 57 Increlex R 57 rNAPc2 57 OHR/AVR# 57 LibiGel ® 57 ACAPODENE 57 NEVO ™ 57 Cimzia ® certolizumab pegol 57 TheraCIM 57 T Pred 57 Squalamine 57 Nexavar ® 57 Tavocept 57 lomitapide 57 Natalizumab 57 Riquent 57 Elocalcitol 57 RNAi therapeutic targeting PCSK9 57 interferon beta therapy 57 TYKERB 57 Cloretazine R VNP#M 57 PRISTIQ 57 antisense drug 57 davunetide 57 telbivudine 57 confirmatory Phase III 57 oral FTY# 57 MGCD# [001] 57 Arikace 57 STEEN Solution ™ 56 ThGRF 56 masitinib 56 velafermin 56 VitiGam 56 Bicifadine 56 cartilage regeneration 56 oral rivaroxaban 56 lintuzumab 56 Zingo TM 56 Zelrix 56 Leukine 56 Ataluren 56 Marqibo 56 transcatheter valve 56 BHT DNA 56 TKM ApoB 56 diabetic neuropathic pain 56 PROVENGE ® 56 dexanabinol 56 Tarceva TM 56 favorable pharmacokinetic profile 56 CGEN # 56 Troxatyl 56 RSD# 56 oral anticoagulant 56 Vernakalant 56 Cethromycin 56 PROCHYMAL 56 Zerenex 56 Unit Dose Budesonide 56 PRTX 56 pharmacokinetic PK 56 Viprinex 56 tamibarotene 56 ACTEMRA 56 AGHD 56 placebo controlled clinical 56 Multimeric 56 tocilizumab 56 ATL/TV# 56 HspE7 56 Reclast Aclasta 56 NLX P# 56 canakinumab 56 GALNS 56 eTag assays 56 M6G 56 TREANDA 56 IV APAP 56 MAP# 56 NeuroFlo 56 Rebif ® 56 CMV vaccine 56 BST CarGel R 56 BENLYSTA ® 56 COPAXONE R 56 Selective Electrochemical Tumor Ablation 56 Carfilzomib 56 ReN# 56 TRIOLEX 56 alteplase 56 MabCampath 56 valopicitabine 56 Phase IIa clinical 56 otelixizumab 56 SCIB1 56 Revascor TM 56 Elafin 56 xanthine oxidase inhibitor 56 Asentar 56 Lubiprostone 56 Somatuline R Depot 56 lumiliximab 56 GGF2 56 OPAXIO 56 MAXY G# 56 SomatoKine 56 BEMA Buprenorphine 56 urethral bulking agent 56 Ambrisentan 56 Ophena 56 Toraymyxin TM 56 targeting CD# 56 Phase 1b trial 56 Eculizumab 56 Phase 2a trial 56 sorafenib tablets 56 Vectibix panitumumab 56 AZX# 56 ZYBRESTAT 56 pan HDAC inhibitor 56 bardoxolone 56 sitaxsentan 56 Glatiramer Acetate 56 uricase 56 MNTX 56 R#/MEM # 56 RHUCIN 56 SARMs 56 investigational therapies 56 Phase Ib clinical 56 delafloxacin 56 omecamtiv mecarbil 56 Advexin 56 Thrombolysis 56 rALLy trial 56 Naproxcinod 56 L MTP PE 56 TELINTRA 56 Emezine 56 PLX PAD 56 hyperphenylalaninemia HPA due 56 TroVax ® 56 Arimoclomol 56 novel peptide 56 TBC# 56 Genz # 56 Plasmin 56 Apoptone 55 Urocidin 55 invasive candidiasis 55 ZFP TF 55 Velcade bortezomib 55 bazedoxifene 55 LEX System 55 registrational 55 DDP# 55 RoACTEMRA 55 coronary stenting 55 Cimzia ® 55 THALOMID 55 mTOR inhibition 55 ACZ# 55 Amigal 55 GRNCM1 55 intracoronary 55 TriRima 55 PRADAXA 55 cediranib 55 Naglazyme 55 phase IIb 55 adalimumab 55 AGGRASTAT ® 55 RAPTIVA 55 efalizumab 55 SCIg 55 lesinurad 55 Adentri 55 REBETOL combination therapy 55 daclizumab 55 RhuDex 55 relapsed ALL 55 Neo Bladder Augment 55 Revimmune 55 ISF# 55 Zemplar Capsules 55 INC# 55 QT QTc 55 oral methylnaltrexone 55 Onco TCS 55 Oral NKTR 55 ONTAK 55 ambrisentan 55 JANUVIA 55 tolvaptan 55 SERCA2a 55 varespladib 55 Alzhemed TM 55 icatibant 55 CRLX# 55 micafungin 55 Onrigin 55 NOXAFIL 55 axitinib 55 Vascugel ® 55 Laquinimod 55 ALTACE 55 pertuzumab 55 MDV# 55 FOLOTYN 55 tolevamer 55 Reolysin 55 brivaracetam 55 DAVANAT 55 Phase IIa trials 55 hylan GF 55 AFRS TM 55 Glybera 55 noninfectious uveitis 55 CYCLOSET 55 FIRAZYR 55 clinical pharmacology studies 55 intranasal delivery 55 myoblast therapy 55 Acetavance 55 decitabine 55 custirsen 55 antitumor effect 55 Cimzia R 55 Multaq R 55 BNC# 55 forodesine 55 amrubicin 55 Mipomersen 55 Panzem R NCD 55 Hsp# inhibition 55 Carticel 55 aripiprazole Abilify 55 CIMZIA TM 55 selective modulator 55 alemtuzumab MS 55 Frova ® 55 Soliris TM eculizumab 55 EDEMA3 trial 55 Etanercept 55 PD LID 55 Ixempra 55 Glufosfamide 55 Fabry Disease 55 CRx 55 ATryn R 55 BrachySil TM 55 sargramostim 55 calcitonin 55 neurologic progression 55 HuCNS SC 55 opioid induced bowel dysfunction 55 NATRECOR ® 55 lurasidone 55 FIRMAGON R 55 Rivaroxaban 55 SinuNase 55 Dacogen injection 55 ESBA# 55 pharmacodynamic properties 55 plasma pharmacokinetics 55 Isolagen Therapy 55 ENMD # 55 Ranexa R 55 PEG INTRON 55 tipranavir 55 romiplostim 55 BAL# [002] 55 relapsed MM 55 Serdaxin 55 p# biomarker 55 Ketotransdel 55 RE LY ® 55 AGGRASTAT R 55 Aryplase 55 Tasimelteon 55 MP4OX 55 oral calcitonin 55 NPSP# 55 nephrotoxicity 55 PET tracers 55 Prestara 55 hoFH 55 HGS# 54 ecallantide 54 zileuton 54 denufosol 54 Xenazine ® 54 JAK inhibitors 54 SILENOR TM 54 Jevtana 54 Acapodene 54 febuxostat 54 registrational trial 54 Abiraterone 54 MitraClip device 54 Ocrelizumab 54 bioabsorbable stent 54 AMEVIVE 54 SANVAR 54 PFO closure 54 Nebido 54 immune modulation 54 ticagrelor 54 QNEXA 54 vivo potency 54 Rescula 54 silodosin 54 IMiDs 54 BENLYSTA 54 metastatic hormone refractory 54 PEG PAL 54 anti angiogenic drugs 54 Adalimumab 54 sapacitabine 54 OLEPTRO TM 54 fluvastatin 54 SIR Spheres 54 Zilver PTX 54 thrombolytics 54 Ceflatonin 54 Doxil ® 54 Phase 2b clinical 54 apremilast 54 calcineurin inhibitors 54 DCCR 54 Synavive 54 Otelixizumab 54 Plenaxis R 54 vemurafenib 54 A3 adenosine receptor 54 NB S# 54 PRX # 54 Cethrin R 54 KYNAPID 54 Phase 2a 54 ELADUR 54 biologic therapeutics 54 GOUT 54 PEGylated interferon beta 1a 54 STELARA TM 54 PS# [001] 54 chronic angina 54 IMiDs ® compound 54 GFT# 54 ABILIFY ® 54 pharmacological chaperone 54 Locteron 54 ATryn ® 54 vascular disrupting agents 54 Tectin TM 54 Bendamustine 54 exon skipping 54 NEUGENE 54 rivaroxaban 54 tecarfarin 54 Mozobil 54 Phenserine 54 ocrelizumab 54 TB4 54 ULORIC 54 Memryte 54 gabapentin enacarbil 54 NUVIGIL 54 Neupro R 54 Panitumumab 54 pharmacokinetic equivalence 54 cMET 54 perampanel 54 anti angiogenic therapy 54 β blockers 54 cortical stimulation 54 Allovectin 7 ® 54 Aclasta 54 severe gastroparesis 54 blood clot dissolver 54 Stelara 54 Mylotarg 54 prophylactic therapy 54 percutaneous aortic valve 54 dextromethorphan quinidine 54 oncolytic virus 54 Somatuline Depot 54 Gabapentin GR 54 ELIQUIS 54 NEBIDO 54 Betaferon ® 54 DACH platinum 54 picoplatin 54 Corlux 54 OFIRMEV 54 rBChE 54 Rasilez Tekturna 54 PHX# 54 embolotherapy 54 Sanctura XR 54 phase 2a 54 Ustekinumab 54 anidulafungin 54 glatiramer acetate 54 Dupuytren Contracture 54 Behcet uveitis 54 Phase IIb clinical 54 neurogenic orthostatic hypotension 54 Levetiracetam 54 antithrombotic 54 mycophenolate mofetil 54 alemtuzumab Campath 54 NUEDEXTA 54 Navelbine ® 54 albinterferon alfa 2b 54 Numax 54 ONGLYZA ™ 54 Voraxaze 54 pathogen inactivation 54 CardioFit 54 Src inhibitors 54 caspofungin 54 liposomal amphotericin B 54 Trobalt 54 acadesine 54 crizotinib PF # 54 COPAXONE ® 54 Milnacipran 54 Pixantrone 54 Inhaled AAT 54 Dyloject 54 XGEVA 54 RAPTIVA R 54 aclidinium 54 dimebon 54 KL4 surfactant 54 safinamide 54 INFUSE ® 54 pain palliation 54 adult mesenchymal stem 54 autologous bone marrow 54 Puricase 54 virus HCV protease inhibitor 54 clevidipine 54 AZD# 54 JAK#/JAK# inhibitor CYT# 53 Lodotra 53 DiabeCell ® 53 IIIa inhibitor 53 wilate ® 53 Betaferon R 53 bioartificial liver device 53 TRILIPIX 53 panitumumab 53 GeoVax vaccine 53 CoAxia 53 clinical trials 53 Amphotericin B 53 Reverset 53 PROVIGIL 53 LHRH antagonists 53 ONGLYZA 53 limiting toxicity 53 Arranon 53 renoprotective 53 nonclinical studies 53 cardiac repolarization 53 ranolazine 53 Fludara 53 regadenoson 53 ticagrelor Brilinta 53 Zenvia Phase III 53 ASA# 53 Phase III clinical 53 ofatumumab 53 avanafil 53 molecular biomarkers 53 ezogabine 53 BYDUREON 53 INCB# [002] 53 AA amyloidosis 53 Sandostatin LAR 53 dose escalation Phase 53 teriparatide 53 GSK# [001] 53 Arcalyst 53 StaphVAX 53 Keppra ® 53 treprostinil 53 MRgFUS 53 interferon gamma 1b 53 Sudhir Agrawal D.Phil 53 Phase 2b trial 53 antiarrhythmic drug 53 CIMZIA TM certolizumab pegol 53 Orazol 53 enzastaurin 53 omacetaxine mepesuccinate 53 BARACLUDE R 53 SPARLON 53 MACUGEN 53 ORENCIA ® 53 aleglitazar 53 Pervasis 53 Fampridine SR 53 Ozurdex 53 antiangiogenic agent 53 VPRIV 53 anti angiogenic agents 53 XP #L 53 Nuvion 53 Ceplene 53 Artelon ® 53 everolimus eluting stents 53 Junovan 53 RG# [001] 53 Targretin capsules 53 HIF PH inhibitors 53 Phase Ib 53 FROVA 53 DexaSite 53 immunomodulatory 53 DaTscan 53 Gleevec resistant 53 anti CD# antibodies 53 investigational compound 53 enoximone 53 ancrod 53 fenofibric acid 53 DR Cysteamine 53 #ME# 53 ICA # 53 eculizumab 53 tumor specific antigen 53 Clolar 53 complete cytogenetic response 53 PASI scores 53 NovaBay Aganocide compounds 53 zileuton CR 53 biodistribution 53 Anidulafungin 53 TRISENOX 53 Cetuximab 53 placebo controlled Phase III 53 antifibrotic 53 kidney urologic 53 temsirolimus 53 Levulan PDT 53 pharmacokinetic characteristics 53 ACTEMRA TM 53 MYO VAD 53 isatoribine 53 adenosine injection 53 anticancer therapy 53 paliperidone ER 53 vilazodone 53 Serdolect ® 53 Ticagrelor 53 Vidaza ® 53 visilizumab 53 SILENOR 53 dosage regimens 53 clinically meaningful efficacy 53 oral diclofenac 53 antithrombotics 53 levosimendan 53 class mGluR5 inhibitor 53 AA Amyloidosis 53 JAK2 inhibitor 53 juvenile chondrocytes 53 Hepatocellular Carcinoma HCC 53 pharmacodynamic PD 53 CDK inhibitor 52 NTDDS 52 Ramelteon 52 Campath alemtuzumab 52 clobazam 52 bosentan 52 #F FDG PET 52 Islet transplantation 52 tigecycline 52 Actemra tocilizumab 52 Keppra XR 52 Cell Pouch System 52 LHRH agonists 52 HeartNet 52 Phase 1b clinical 52 ponatinib 52 FACTIVE tablets 52 NATRECOR R 52 Corus CAD 52 Targretin 52 analgesic efficacy 52 ACUITY trial 52 severe hypersensitivity reactions 52 oxymorphone ER 52 thromboembolic events 52 rtPA 52 Vilazodone 52 hematological parameters 52 eslicarbazepine acetate 52 Huntexil 52 bremelanotide 52 TASKi3 52 Genasense 52 CDP# 52 paclitaxel eluting stents 52 SAPHRIS 52 PROVENGE 52 Phase 2b study 52 dopamine partial agonist 52 ALVESCO HFA 52 fibrin sealant 52 severe hypercholesterolemia 52 relapsed MCL 52 Pennsaid R 52 metastatic neuroendocrine tumors 52 Liraglutide 52 HEPLISAV 52 carotid artery stenting 52 tasocitinib 52 Boceprevir 52 efficacy endpoints 52 fondaparinux 52 ischemic cardiomyopathy 52 bosutinib 52 compound INCB# 52 vandetanib 52 imatinib therapy 52 SEROQUEL 52 ustekinumab 52 postoperative ileus 52 MBP# [001] 52 desvenlafaxine succinate 52 vernakalant 52 Arixtra 52 velaglucerase alfa 52 Non inferiority 52 preclinical efficacy 52 biomarker assay 52 Zelapar 52 Cinryze 52 siRNA therapeutics 52 perifosine 52 Ostarine 52 miltefosine 52 adipose derived stem cells 52 Cipralex ® 52 Levadex 52 Litx 52 rhIGF-I/rhIGFBP-3 52 bicifadine 52 Electronic Brachytherapy 52 Synvisc One 52 allogeneic HSCT 52 glufosfamide 52 Radilex 52 lubiprostone 52 pharmacodynamic parameters 52 ISIS # 52 DIFICID 52 TNFa 52 ATIR TM 52 optimal dosing 52 FTY# 52 cladribine tablets 52 oncolytic viruses 52 HoFH 52 angiographic outcomes 52 Gattex 52 dyslipidaemia 52 HER2 expression 52 pharmacodynamic effects 52 Gefitinib 52 NVA# 52 inhibit metastasis 52 Cystectomy 52 gastrointestinal stromal tumors GIST 52 desvenlafaxine 52 pharmacokinetic interactions 52 ZFP Therapeutic 52 ORMD 52 SABCS 52 certolizumab 52 schizophrenia CIAS 52 Doxil 52 linaclotide 52 GMX# 52 Egrifta 52 atherosclerosis regression 52 FFR guided treatment 52 Tolvaptan 52 sunitinib malate 52 PSN# [002] 52 nanoviricide 52 REMICADE ® 52 regenerative medicine therapies 52 HMG CoA reductase inhibitors 52 thromboembolic disease 52 clinically relevant 52 LVAS 52 hMG 52 ViaCyte 52 LBH# 52 Betaseron ® 52 placebo controlled Phase 52 Zalbin 52 clofarabine 52 small molecule activators 52 NPS NPS Pharmaceuticals 52 anti leukemic 52 Flutiform TM 52 VELCADE melphalan 52 dirucotide 52 Myoblast Program 52 Cimzia certolizumab pegol 52 QTc prolongation 52 fidaxomicin 52 aldosterone antagonists